ZA884545B - Functionalized polyamine chelants and rhodium complexes thereof and process for their preparation - Google Patents
Functionalized polyamine chelants and rhodium complexes thereof and process for their preparationInfo
- Publication number
- ZA884545B ZA884545B ZA884545A ZA884545A ZA884545B ZA 884545 B ZA884545 B ZA 884545B ZA 884545 A ZA884545 A ZA 884545A ZA 884545 A ZA884545 A ZA 884545A ZA 884545 B ZA884545 B ZA 884545B
- Authority
- ZA
- South Africa
- Prior art keywords
- preparation
- functionalized polyamine
- rhodium complexes
- chelants
- rhodium
- Prior art date
Links
- 229920000768 polyamine Polymers 0.000 title abstract 2
- 150000003283 rhodium Chemical class 0.000 title abstract 2
- 102000008394 Immunoglobulin Fragments Human genes 0.000 abstract 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 abstract 1
- 229910052703 rhodium Inorganic materials 0.000 abstract 1
- 239000010948 rhodium Substances 0.000 abstract 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C263/00—Preparation of derivatives of isocyanic acid
- C07C263/10—Preparation of derivatives of isocyanic acid by reaction of amines with carbonyl halides, e.g. with phosgene
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6887—Antibody-chelate conjugates using chelates for therapeutic purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0073—Rhodium compounds
- C07F15/008—Rhodium compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/065,739 US4994560A (en) | 1987-06-24 | 1987-06-24 | Functionalized polyamine chelants and radioactive rhodium complexes thereof for conjugation to antibodies |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA884545B true ZA884545B (en) | 1990-02-28 |
Family
ID=22064774
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA884545A ZA884545B (en) | 1987-06-24 | 1988-06-24 | Functionalized polyamine chelants and rhodium complexes thereof and process for their preparation |
Country Status (19)
Country | Link |
---|---|
US (2) | US4994560A (fr) |
EP (1) | EP0296522B1 (fr) |
JP (1) | JP2728437B2 (fr) |
KR (1) | KR970011005B1 (fr) |
CN (1) | CN1022839C (fr) |
AT (1) | ATE143364T1 (fr) |
CA (1) | CA1341349C (fr) |
DE (1) | DE3855564T2 (fr) |
DK (1) | DK343288A (fr) |
ES (1) | ES2091746T3 (fr) |
FI (1) | FI101378B1 (fr) |
GR (1) | GR3021537T3 (fr) |
HK (1) | HK1006168A1 (fr) |
HU (1) | HU201333B (fr) |
IL (1) | IL86835A (fr) |
NO (1) | NO178928C (fr) |
NZ (1) | NZ225070A (fr) |
PT (1) | PT87802B (fr) |
ZA (1) | ZA884545B (fr) |
Families Citing this family (105)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5132409A (en) * | 1987-01-12 | 1992-07-21 | Bracco Industria Chimica S.P.A. | Macrocyclic chelating agents and chelates thereof |
US5006643A (en) * | 1987-06-24 | 1991-04-09 | The Dow Chemical Company | Process for preparing isothiocyanato functionalized metal complexes |
ZA894792B (en) * | 1988-06-24 | 1991-04-24 | Dow Chemical Co | Macrocyclic bifunctional chelants,complexes thereof and their antibody conjugates |
US5756065A (en) * | 1988-06-24 | 1998-05-26 | The Dow Chemical Company | Macrocyclic tetraazacyclododecane conjugates and their use as diagnostic and therapeutic agents |
IL90730A0 (en) * | 1988-06-24 | 1990-01-18 | Dow Chemical Co | Macrocyclic bifunctional chelants,complexes thereof and their antibody conjugates |
JP2930709B2 (ja) * | 1988-12-22 | 1999-08-03 | ザ ダウ ケミカル カンパニー | モノ―n―アルキル化ポリアザ大員環の製造方法 |
JP2930708B2 (ja) * | 1988-12-23 | 1999-08-03 | ザ ダウ ケミカル カンパニー | イソチオシアナト官能化金属錯体の製造方法 |
US5292868A (en) * | 1989-05-26 | 1994-03-08 | Akzo N.V. | Chelating agents for attaching metal ions to proteins |
US5808003A (en) * | 1989-05-26 | 1998-09-15 | Perimmune Holdings, Inc. | Polyaminocarboxylate chelators |
DE3930674A1 (de) * | 1989-09-11 | 1991-03-21 | Diagnostikforschung Inst | Bifunktionelle chelatbildner zur komplexierung von tc- und re-isotopen, verfahren zu ihrer herstellung und darstellung von konjugaten daraus sowie deren verwendung in diagnostik und therapie |
WO1991010669A1 (fr) * | 1990-01-19 | 1991-07-25 | Cockbain, Julian, Roderick, Michaelson | Composes de chelation |
AU7587091A (en) * | 1990-03-26 | 1991-10-21 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | A fonctionalized complexand |
US5283293A (en) * | 1990-12-14 | 1994-02-01 | Corvas, Inc. | Reagents for automated synthesis of peptide analogs |
GB9105489D0 (en) * | 1991-03-15 | 1991-05-01 | Johnson Matthey Plc | Improvements in chemical compounds |
DE4140779A1 (de) * | 1991-12-06 | 1993-06-09 | Schering Ag Berlin Und Bergkamen, 1000 Berlin, De | Verfahren zur herstellung von mono-n-substituierten tetraazamakrocyclen |
US5410043A (en) * | 1991-12-06 | 1995-04-25 | Schering Aktiengesellschaft | Process for the production of mono-N-substituted tetraaza macrocycles |
GB9126677D0 (en) * | 1991-12-16 | 1992-02-12 | Johnson Matthey Plc | Improvements in chemical compounds |
WO1993020852A2 (fr) * | 1992-04-13 | 1993-10-28 | The Dow Chemical Company | Agents de chelation macrocycliques, leurs chelates et conjugues |
US5310535A (en) * | 1992-04-24 | 1994-05-10 | The Dow Chemical Company | Carboxamide modified polyamine chelators and radioactive complexes thereof for conjugation to antibodies |
DE4218744C2 (de) * | 1992-06-04 | 1997-11-06 | Schering Ag | Verfahren zur Herstellung von N-ß-Hxdroxyalkyl-tri-N-carboxylalkyl-1,4,7,10-tetraazacyclododecan- und N-ß-Hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecan-Derivaten und deren Metallkomplexe |
EP0588229A3 (en) * | 1992-09-12 | 1994-06-15 | Hoechst Ag | Macrocyclic chelating agents for the preparation of technetium or rhenium complexes |
AU2194695A (en) * | 1994-03-28 | 1995-10-17 | Regents Of The University Of California, The | Method for preparing radionuclide-labeled chelating agent-ligand complexes |
CN1152880A (zh) * | 1994-04-22 | 1997-06-25 | 孟山都公司 | 使用含氮大环配拉体的金属络合物的诊断图像分析的方法 |
WO1995029925A1 (fr) * | 1994-04-29 | 1995-11-09 | The Curators Of The University Of Missouri | Composes thioether destines a la preparation d'agents chelateurs bifonctionnels pour des produits radiopharmaceutiques therapeutiques |
US7820798B2 (en) * | 1994-11-07 | 2010-10-26 | Human Genome Sciences, Inc. | Tumor necrosis factor-gamma |
US7597886B2 (en) * | 1994-11-07 | 2009-10-06 | Human Genome Sciences, Inc. | Tumor necrosis factor-gamma |
US5663161A (en) * | 1995-02-17 | 1997-09-02 | The Research Foundation Of State University Of New York | Anti-viral triaza compounds |
US5719033A (en) * | 1995-06-28 | 1998-02-17 | Motorola, Inc. | Thin film transistor bio/chemical sensor |
EP0835233B1 (fr) * | 1995-06-28 | 2001-12-05 | NEN Life Science Products, Inc. | Composition et procede de stabilisation de composes organiques radiomarques |
JPH11511168A (ja) | 1995-08-17 | 1999-09-28 | モンサント カンパニー | 窒素含有大環状リガンドの金属錯体の生体分子結合体を使用する診断造影検査方法 |
US5871436A (en) * | 1996-07-19 | 1999-02-16 | Advanced Cardiovascular Systems, Inc. | Radiation therapy method and device |
US5782740A (en) * | 1996-08-29 | 1998-07-21 | Advanced Cardiovascular Systems, Inc. | Radiation dose delivery catheter with reinforcing mandrel |
US6143849A (en) * | 1996-11-27 | 2000-11-07 | The United States Of America As Represented By The Secretary Of The Navy | Synthesis of acrylate and alkyl acrylate monomers and polymers of chelators |
US6776792B1 (en) * | 1997-04-24 | 2004-08-17 | Advanced Cardiovascular Systems Inc. | Coated endovascular stent |
US6210312B1 (en) | 1997-05-20 | 2001-04-03 | Advanced Cardiovascular Systems, Inc. | Catheter and guide wire assembly for delivery of a radiation source |
US6159140A (en) * | 1998-02-17 | 2000-12-12 | Advanced Cardiovascular Systems | Radiation shielded catheter for delivering a radioactive source and method of use |
US6159139A (en) * | 1998-02-17 | 2000-12-12 | Advanced Cardiovascular Systems Inc. | Radiation delivery catheter with a spring wire centering mechanism |
US6224535B1 (en) | 1998-02-17 | 2001-05-01 | Advanced Cardiovascular Systems, Inc. | Radiation centering catheters |
US6235363B1 (en) | 1998-05-06 | 2001-05-22 | Avery Dennison Corporation | Composite construction containing barrier layer |
JP2002537769A (ja) | 1999-02-26 | 2002-11-12 | ヒューマン ジノーム サイエンシーズ, インコーポレイテッド | ヒトエンドカインαおよび使用方法 |
US6790228B2 (en) * | 1999-12-23 | 2004-09-14 | Advanced Cardiovascular Systems, Inc. | Coating for implantable devices and a method of forming the same |
US6605031B1 (en) | 1999-09-22 | 2003-08-12 | Advanced Cardiovascular Systems, Inc. | Stepped centering balloon for optimal radiation delivery |
US6582417B1 (en) | 1999-09-22 | 2003-06-24 | Advanced Cardiovascular Systems, Inc. | Methods and apparatuses for radiation treatment |
US7994449B2 (en) | 2000-02-16 | 2011-08-09 | Advanced Cardiovascular Systems, Inc. | Square-wave laser bonding |
US7163504B1 (en) | 2000-02-16 | 2007-01-16 | Advanced Cardiovascular Systems, Inc. | Multi-lumen fluted balloon radiation centering catheter |
EP1276756A4 (fr) | 2000-04-12 | 2004-06-09 | Human Genome Sciences Inc | Proteines de fusion d'albumine |
WO2001096528A2 (fr) | 2000-06-15 | 2001-12-20 | Human Genome Sciences, Inc. | Facteur de necrose tumorale humain delta et epsilon |
PT2281843T (pt) | 2000-06-16 | 2017-01-02 | Human Genome Sciences Inc | Anticorpos que se ligam imunoespecificamente a blys |
US6783793B1 (en) * | 2000-10-26 | 2004-08-31 | Advanced Cardiovascular Systems, Inc. | Selective coating of medical devices |
US6764505B1 (en) * | 2001-04-12 | 2004-07-20 | Advanced Cardiovascular Systems, Inc. | Variable surface area stent |
AU2002309647C1 (en) | 2001-05-25 | 2008-09-11 | Human Genome Sciences, Inc. | Antibodies that immunospecifically bind to trail receptors |
US7862495B2 (en) * | 2001-05-31 | 2011-01-04 | Advanced Cardiovascular Systems, Inc. | Radiation or drug delivery source with activity gradient to minimize edge effects |
US6565659B1 (en) * | 2001-06-28 | 2003-05-20 | Advanced Cardiovascular Systems, Inc. | Stent mounting assembly and a method of using the same to coat a stent |
US6656216B1 (en) * | 2001-06-29 | 2003-12-02 | Advanced Cardiovascular Systems, Inc. | Composite stent with regioselective material |
LT2371361T (lt) | 2001-07-31 | 2019-09-10 | Genzyme Corporation | Pirmtakų/kamieninių ląstelių suaktyvinimo būdai |
ES2545090T3 (es) | 2001-12-21 | 2015-09-08 | Human Genome Sciences, Inc. | Proteínas de fusión de albúmina y GCSF |
US20080194481A1 (en) | 2001-12-21 | 2008-08-14 | Human Genome Sciences, Inc. | Albumin Fusion Proteins |
AU2003218456A1 (en) * | 2002-04-01 | 2003-10-20 | Human Genome Sciences, Inc. | Antibodies that specifically bind to gmad |
JP2005535572A (ja) | 2002-04-12 | 2005-11-24 | メディミューン,インコーポレーテッド | 組換え抗インターロイキン−9抗体 |
JP4643255B2 (ja) * | 2002-06-10 | 2011-03-02 | バクシネックス インコーポレーティッド | 乳癌および膀胱癌において差次的に発現される遺伝子ならびにコードされるポリペプチド |
US7169178B1 (en) * | 2002-11-12 | 2007-01-30 | Advanced Cardiovascular Systems, Inc. | Stent with drug coating |
US20040142495A1 (en) * | 2002-12-16 | 2004-07-22 | Hartman William G. | Analyte detecting article and method |
US7198675B2 (en) * | 2003-09-30 | 2007-04-03 | Advanced Cardiovascular Systems | Stent mandrel fixture and method for selectively coating surfaces of a stent |
GB0416062D0 (en) * | 2004-07-19 | 2004-08-18 | Amersham Plc | Improved N4 chelator conjugates |
AU2004296184B2 (en) * | 2003-12-04 | 2010-12-16 | Vaccinex, Inc. | Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells |
US7563324B1 (en) | 2003-12-29 | 2009-07-21 | Advanced Cardiovascular Systems Inc. | System and method for coating an implantable medical device |
HUE027902T2 (en) | 2004-02-09 | 2016-11-28 | Human Genome Sciences Inc Corp Service Company | Albumin fusion proteins |
US7973139B2 (en) * | 2004-03-26 | 2011-07-05 | Human Genome Sciences, Inc. | Antibodies against nogo receptor |
US7553377B1 (en) | 2004-04-27 | 2009-06-30 | Advanced Cardiovascular Systems, Inc. | Apparatus and method for electrostatic coating of an abluminal stent surface |
US20050288481A1 (en) * | 2004-04-30 | 2005-12-29 | Desnoyer Jessica R | Design of poly(ester amides) for the control of agent-release from polymeric compositions |
US7632307B2 (en) | 2004-12-16 | 2009-12-15 | Advanced Cardiovascular Systems, Inc. | Abluminal, multilayer coating constructs for drug-delivery stents |
US20060216431A1 (en) * | 2005-03-28 | 2006-09-28 | Kerrigan Cameron K | Electrostatic abluminal coating of a stent crimped on a balloon catheter |
EP1891111A1 (fr) | 2005-05-06 | 2008-02-27 | ZymoGenetics, Inc. | Anticorps monoclonaux il-31 et procedes d'utilisation associes |
US7867547B2 (en) | 2005-12-19 | 2011-01-11 | Advanced Cardiovascular Systems, Inc. | Selectively coating luminal surfaces of stents |
US20070148251A1 (en) * | 2005-12-22 | 2007-06-28 | Hossainy Syed F A | Nanoparticle releasing medical devices |
BRPI0709338A2 (pt) | 2006-03-21 | 2011-07-12 | Genentech Inc | anticorpo, molécula de ácido nucleico isolada, célula, composições, método de detecção da proteìna alfa5beta1, uso de anticorpo, métodos de tratamento, kit, uso de uma composição, uso de uma antagonista de alfa5beta e uso de uma antagonista de vegf |
US8069814B2 (en) | 2006-05-04 | 2011-12-06 | Advanced Cardiovascular Systems, Inc. | Stent support devices |
US8603530B2 (en) * | 2006-06-14 | 2013-12-10 | Abbott Cardiovascular Systems Inc. | Nanoshell therapy |
US8048448B2 (en) * | 2006-06-15 | 2011-11-01 | Abbott Cardiovascular Systems Inc. | Nanoshells for drug delivery |
AU2007261247A1 (en) * | 2006-06-22 | 2007-12-27 | Vaccinex, Inc. | Anti-C35 antibodies for treating cancer |
US8017237B2 (en) | 2006-06-23 | 2011-09-13 | Abbott Cardiovascular Systems, Inc. | Nanoshells on polymers |
ES2548714T3 (es) | 2006-09-01 | 2015-10-20 | Zymogenetics, Inc. | Anticuerpos monoclonales IL-31 y procedimientos de uso |
WO2008105473A1 (fr) * | 2007-02-28 | 2008-09-04 | National University Corporation Chiba University | Agent anti-tumeur maligne |
US8048441B2 (en) | 2007-06-25 | 2011-11-01 | Abbott Cardiovascular Systems, Inc. | Nanobead releasing medical devices |
AU2008333131B2 (en) | 2007-12-07 | 2013-10-24 | Merck Serono S/A | Humanized antibody molecules specific for IL-31 |
AU2008341050B2 (en) * | 2007-12-26 | 2013-10-24 | Vaccinex, Inc. | Anti-C35 antibody combination therapies and methods |
CA2751161C (fr) | 2008-12-30 | 2018-10-02 | Children's Medical Center Corporation | Procede de prediction d'une appendicite aigue |
PE20120770A1 (es) | 2009-03-25 | 2012-07-10 | Genentech Inc | ANTICUERPOS ANTI alfa5ß1 CON ACTIVIDAD SOBRE GLIOBLASTOMAS |
EP2464622B1 (fr) * | 2009-10-08 | 2014-07-23 | ANGUS Chemical Company | Polyamines pauvres en voc |
US20110293629A1 (en) | 2010-05-14 | 2011-12-01 | Bastid Jeremy | Methods of Treating and/or Preventing Cell Proliferation Disorders with IL-17 Antagonists |
GB201008584D0 (en) * | 2010-05-22 | 2010-07-07 | Univ Warwick | Novel iridium anti-cancer compounds |
US10384078B2 (en) * | 2013-10-15 | 2019-08-20 | Ip Liberty Vision Corporation | Polymeric radiation-sources |
PT3148581T (pt) | 2014-05-30 | 2020-01-06 | Henlix Biotech Co Ltd | Anticorpos antirrecetor do fator de crescimento epidérmico (egfr) |
EP3029032A1 (fr) * | 2014-12-05 | 2016-06-08 | Centre National de la Recherche Scientifique (CNRS) | Dérivés do2pa bifonctionnels, chélates possédant des cations métalliques et leurs utilisation |
RU2754041C2 (ru) | 2015-04-03 | 2021-08-25 | Еурека Терапьютикс, Инк. | Конструкции, направленные на комплексы пептида afp/мнс, и виды их использования |
CN107787332B (zh) | 2015-04-24 | 2022-09-09 | 豪夫迈·罗氏有限公司 | 多特异性抗原结合蛋白 |
WO2018052818A1 (fr) | 2016-09-16 | 2018-03-22 | Henlix, Inc. | Anticorps anti-pd-1 |
US11274157B2 (en) | 2017-01-12 | 2022-03-15 | Eureka Therapeutics, Inc. | Constructs targeting histone H3 peptide/MHC complexes and uses thereof |
US11447564B2 (en) | 2017-04-26 | 2022-09-20 | Eureka Therapeutics, Inc. | Constructs specifically recognizing glypican 3 and uses thereof |
RU2020128013A (ru) | 2018-03-14 | 2022-04-15 | Бейцзин Сюаньи Фармасайенсиз Ко., Лтд. | Антитела против клаудина 18.2 |
WO2019245991A1 (fr) | 2018-06-18 | 2019-12-26 | Eureka Therapeutics, Inc. | Constructions ciblant un antigène membranaire spécifique à la prostate (psma) et leurs utilisations |
CN112300279A (zh) | 2019-07-26 | 2021-02-02 | 上海复宏汉霖生物技术股份有限公司 | 针对抗cd73抗体和变体的方法和组合物 |
CN110818795B (zh) | 2020-01-10 | 2020-04-24 | 上海复宏汉霖生物技术股份有限公司 | 抗tigit抗体和使用方法 |
CA3240565A1 (fr) | 2021-12-17 | 2023-06-22 | Wenfeng Xu | Anticorps anti-ox40 et procedes d'utilisation |
WO2023109900A1 (fr) | 2021-12-17 | 2023-06-22 | Shanghai Henlius Biotech, Inc. | Anticorps anti-ox40, anticorps multispécifiques et procédés d'utilisation |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2803528C2 (de) * | 1977-03-09 | 1984-10-18 | Tabushi, Iwao, Kyoto | Schwermetallionen-Adsorbens und dessen Verwendung zum Adsorbieren von Schwermetallionen |
US4622420A (en) * | 1980-03-18 | 1986-11-11 | The Regents Of The University Of California | Chelating agents and method |
US4454106A (en) * | 1982-06-07 | 1984-06-12 | Gansow Otto A | Use of metal chelate conjugated monoclonal antibodies |
US4479930A (en) * | 1982-07-26 | 1984-10-30 | Trustees Of The University Of Massachusetts | Amines coupled wth dicyclic dianhydrides capable of being radiolabeled product |
US4615876A (en) * | 1983-04-25 | 1986-10-07 | Curators Of The University Of Missouri | Macrocyclic complexes of technetium-99m for use as diagnostic radionuclides |
US4678667A (en) * | 1985-07-02 | 1987-07-07 | 501 Regents of the University of California | Macrocyclic bifunctional chelating agents |
US4885363A (en) * | 1987-04-24 | 1989-12-05 | E. R. Squibb & Sons, Inc. | 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs |
GB8603537D0 (en) * | 1986-02-13 | 1986-03-19 | Parker D | Conjugate compound |
US5057302A (en) * | 1987-02-13 | 1991-10-15 | Abbott Laboratories | Bifunctional chelating agents |
US5006643A (en) * | 1987-06-24 | 1991-04-09 | The Dow Chemical Company | Process for preparing isothiocyanato functionalized metal complexes |
-
1987
- 1987-06-24 US US07/065,739 patent/US4994560A/en not_active Expired - Fee Related
-
1988
- 1988-06-15 CA CA000569508A patent/CA1341349C/fr not_active Expired - Fee Related
- 1988-06-17 NZ NZ225070A patent/NZ225070A/xx unknown
- 1988-06-20 DE DE3855564T patent/DE3855564T2/de not_active Expired - Fee Related
- 1988-06-20 ES ES88109799T patent/ES2091746T3/es not_active Expired - Lifetime
- 1988-06-20 EP EP88109799A patent/EP0296522B1/fr not_active Expired - Lifetime
- 1988-06-20 AT AT88109799T patent/ATE143364T1/de not_active IP Right Cessation
- 1988-06-22 IL IL8683588A patent/IL86835A/en not_active IP Right Cessation
- 1988-06-22 DK DK343288A patent/DK343288A/da not_active Application Discontinuation
- 1988-06-23 NO NO882784A patent/NO178928C/no not_active IP Right Cessation
- 1988-06-23 PT PT87802A patent/PT87802B/pt not_active IP Right Cessation
- 1988-06-23 HU HU883188A patent/HU201333B/hu not_active IP Right Cessation
- 1988-06-23 FI FI883046A patent/FI101378B1/fi not_active IP Right Cessation
- 1988-06-24 JP JP63155058A patent/JP2728437B2/ja not_active Expired - Fee Related
- 1988-06-24 ZA ZA884545A patent/ZA884545B/xx unknown
- 1988-06-24 KR KR1019880007673A patent/KR970011005B1/ko not_active IP Right Cessation
- 1988-06-24 CN CN88104543A patent/CN1022839C/zh not_active Expired - Fee Related
-
1990
- 1990-11-28 US US07/619,153 patent/US5284644A/en not_active Expired - Lifetime
-
1996
- 1996-11-06 GR GR960402911T patent/GR3021537T3/el unknown
-
1998
- 1998-06-13 HK HK98105268A patent/HK1006168A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1006168A1 (en) | Functionalized polyamine chelants and rhodium complexes thereof and process for their preparation | |
KR0137930B1 (en) | Process for preparing isothiocyanato functionalized metal complexes | |
DE3885946D1 (de) | Kompositstrukturen und Verfahren zum Herstellen derselben. | |
OA08694A (fr) | Acides 3-pyrrolidinylthio-1-azabicyclo [3.2.0] -hept-2-ène-2-carboxyliques et procédés pour leur préparation. | |
DE3871063D1 (de) | Faser-wickel mit innenabzug und verfahren zum herstellen des wickels. | |
NO885704D0 (no) | Tyggegummiblanding med redusert fuktighetsopptak og fremgangsmaate for fremstilling derav. | |
EP0301665A3 (en) | Functionalized polymers and process for the preparation thereof | |
DE3888009D1 (de) | Verfahren zur Bildung eines Schichtkörpers und das sich daraus ergebende Produkt. | |
FI885692A0 (fi) | Karboksimetyylisulfoetyyliselluloosa ja menetelmä sen valmistamiseksi | |
DE3856144D1 (de) | Durch Prägen formbares Material | |
EP0394439A4 (en) | Ultrasonic diagnostic apparatus | |
BE841248A (fr) | Procede de preparation d'un corps composite et corps composite ainsi obtenu | |
PT73516B (en) | Process for the preparation of the antibiotics designated as s 41062/f-6 and s-41062/f-7 with pharmaceutical effect | |
EP0320211A3 (en) | Tetracarboxylic acid anhydride having disiloxane linkage and process for producing the same | |
EP0286131A3 (en) | Perfluoro-2,3,4-trimethylpentane and process for the preparation thereof | |
EP0296495A3 (en) | Process for the preparation of diamines | |
AU614973C (en) | Functionalized polyamine chelants and rhodium complexes thereof and process for their preparation | |
EP0307777A3 (en) | 2-methyl-4-fluoro-phenols and process for their preparation | |
ZA868404B (en) | Pharmaceutical compositions for use in improving oxygenation of the brain and a process for their production | |
PH23924A (en) | Murine hypridoma lym-2 and diagnostic antibody produced thereby | |
IL84465A0 (en) | Murine hybridome lym-2 and diagnostic antibody produced thereby | |
EP0307899A3 (en) | Potentiometer and process for its production | |
DK629587D0 (da) | Taendroer med foroeget taendeffekt | |
DK670188D0 (da) | Taendroer med foroeget taendeffekt |